_1777370220974_847775619.png&w=48&q=75){kind=small}
Netflix exec loses job over ketamine confession
President Trump signed an executive order directing the FDA to review psychedelics designated as breakthrough therapy drugs for the treatment of PTSD and other mental health conditions. The move has garnered support from veterans and advocates, emphasizing potential new therapies.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)